{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:29:49Z","timestamp":1787909389604,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T00:00:00Z","timestamp":1642291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.biopha.2022.112653","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T23:45:50Z","timestamp":1642808750000},"page":"112653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Transcriptional regulation of chemokine network by biologic monotherapy in ileum of patients with Crohn\u2019s disease"],"prefix":"10.1016","volume":"147","author":[{"given":"Raquel","family":"Linares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"M\u00e1rquez-Galera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Caparr\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Madero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artemio","family":"Pay\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 P.","family":"L\u00f3pez-Atalaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Franc\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.112653_bib1","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn's disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.112653_bib2","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.112653_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/bs.ai.2018.02.002","article-title":"Chemokines: critical regulators of memory T cell development, maintenance, and function","volume":"138","author":"Rahimi","year":"2018","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.biopha.2022.112653_bib4","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","article-title":"Targeting immune cell circuits and trafficking in inflammatory bowel disease","volume":"20","author":"Neurath","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2022.112653_bib5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines\u2013chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.112653_bib6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1189\/jlb.1206726","article-title":"Intracellular signaling required for CCL25-stimulated T cell adhesion mediated by the integrin alpha4beta1","volume":"82","author":"Parmo-Cabanas","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2022.112653_bib7","doi-asserted-by":"crossref","first-page":"G1257","DOI":"10.1152\/ajpgi.00266.2007","article-title":"CCL25 and CCL28 promote alpha4 beta7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow","volume":"294","author":"Miles","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2022.112653_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ajg.2010.392","article-title":"The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn\u2019s and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?","volume":"106","author":"D\u2019Haens","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2022.112653_bib9","first-page":"760","article-title":"Loss of response and requirement of infliximab dose intensification in Crohn\u2019s disease: a review","volume":"104","author":"Gisbert","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2022.112653_bib10","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.112653_bib11","article-title":"Five-year efficacy and safety of ustekinumab treatment in Crohn\u2019s disease: the IM-UNITI trial","author":"Sandborn","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2022.112653_bib12","first-page":"412","article-title":"Long-term efficacy of vedolizumab for Crohn\u2019s disease","volume":"11","author":"Vermeire","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.biopha.2022.112653_bib13","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1053\/j.gastro.2004.02.072","article-title":"From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation","volume":"126","author":"Sands","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.112653_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ecco-jcc\/jjx117","article-title":"The expanding therapeutic armamentarium for inflammatory bowel disease: how to choose the right drug[s] for our patients?","volume":"12","author":"Hindryckx","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.biopha.2022.112653_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjab051","article-title":"Results of the seventh scientific workshop of ECCO: precision medicine in IBD \u2013 what, why, and how","author":"Fiocchi","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.biopha.2022.112653_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0065-2776(01)78002-9","article-title":"Chemokines in immunity","volume":"78","author":"Yoshie","year":"2001","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.biopha.2022.112653_bib17","doi-asserted-by":"crossref","first-page":"S641","DOI":"10.1093\/ecco-jcc\/jjx145","article-title":"Chemokines and chemokine receptors as therapeutic targets in inflammatory bowel disease; pitfalls and promise","volume":"12","author":"Trivedi","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.biopha.2022.112653_bib18","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/ecco-jcc\/jjz010","article-title":"CD4+ tissue-resident memory T cells expand and are a major source of mucosal tumour necrosis factor alpha in active Crohn\u2019s disease","volume":"13","author":"Bishu","year":"2019","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.biopha.2022.112653_bib19","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1172\/JCI121668","article-title":"IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease","volume":"129","author":"Belarif","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2022.112653_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/gast.2001.27154","article-title":"CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease","volume":"121","author":"Papadakis","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.112653_bib21","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.4049\/jimmunol.178.5.3293","article-title":"Phenotype and effector function of CC chemokine receptor 9-expressing lymphocytes in small intestinal Crohn\u2019s disease","volume":"178","author":"Saruta","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2022.112653_bib22","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1021\/acs.jmedchem.5b01840","article-title":"A new series of orally bioavailable chemokine receptor 9 (CCR9) antagonists; possible agents for the treatment of inflammatory bowel disease","volume":"59","author":"Kalindjian","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112653_bib23","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/apt.13398","article-title":"Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn\u2019s disease","volume":"42","author":"Feagan","year":"2015","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.biopha.2022.112653_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/smim.2000.0311","article-title":"The role of epithelial cells in immune regulation in the gut","volume":"13","author":"Shao","year":"2001","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biopha.2022.112653_bib25","doi-asserted-by":"crossref","first-page":"G1263","DOI":"10.1152\/ajpgi.00409.2006","article-title":"MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice","volume":"292","author":"Katchar","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2022.112653_bib26","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0016-5085(97)70175-6","article-title":"The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease","volume":"113","author":"Z'Graggen","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.112653_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imr.12757","article-title":"Exploring the complex role of chemokines and chemoattractants in vivo on leukocyte dynamics","volume":"289","author":"David","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2022.112653_bib28","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1365-2036.2011.04866.x","article-title":"Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature","volume":"34","author":"Cullen","year":"2011","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2022.112653_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2022.112653_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2022.112653_bib31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0016-5085(94)90691-2","article-title":"Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel diseases","volume":"106","author":"Salmi","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2022.112653_bib32","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0140-6736(98)05050-8","article-title":"Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease","volume":"352","author":"Binion","year":"1998","journal-title":"Lancet"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:46:14Z","timestamp":1760100374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222000415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":32,"alternative-id":["S0753332222000415"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112653","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptional regulation of chemokine network by biologic monotherapy in ileum of patients with Crohn\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112653"}}